Dr. Lal Path Labs Ltd. has informed the Exchange about General Updates - Update on Acquisition

Listed Co AcquisitionStrategic Transactions View source PDF

LALPATHLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+11.6%1-day move

₹1374.00

prior close

₹1390.40

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+1.7+3.8+2.9+5.7+11.6+15.1+12.5+20.5+19.9+15.6+16.8+13.0+23.1—

Up moveDown movePending

AI summary

Dr. Lal Path Labs has completed acquisition of 100% stake in Shahbazkers Diagnostic Centre Private Limited (SDCPL) on May 1, 2026. With this completion, SDCPL has become a Wholly Owned Subsidiary of the company. The acquisition was carried out as per the terms and conditions of the Share Purchase Agreement. The company had informed the exchange about this proposed acquisition on April 30, 2026, and has now confirmed its successful completion.

Likely market impact

The acquisition strengthens Dr. Lal Path Labs' diagnostic network and service reach by adding SDCPL as a wholly owned subsidiary, potentially expanding revenue and market presence in the diagnostics segment.